Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7438626
Reference Type
Journal Article
Title
Antiarrhythmic Medications
Author(s)
Gomes, JA; ,
Year
2020
Publisher
Springer International Publishing
Location
Cham
Book Title
Heart Rhythm Disorders
Page Numbers
305-333
DOI
10.1007/978-3-030-45066-3_22
URL
http://link.springer.com/10.1007/978-3-030-45066-3_22
Exit
Abstract
Until the advent of ablative therapy and the implantable defibrillator, antiarrhythmic drugs (AADs) were the mainstay in the short- and long-term management of cardiac arrhythmias. In this chapter, the author provides a historical overview of AADs, their classification according to the Singh–Vaughan Williams, and the more recent Sicilian Gambit Classification, the debacle of the CAST study, and details the pharmacotherapy of different classes of AADs and outlines general principles in the use of AADs.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity